4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-22-010452
Chief Medical Officer acquired 60,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eisner Mark Chief Medical Officer | 2022-02-14 | Grant or award | +60,000 | 158,139 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eisner Mark Chief Medical Officer | 2022-02-14 | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…